Login / Signup

International Bladder Cancer Group Intermediate-risk Non-muscle Invasive Bladder Cancer (IBCG IR-NMIBC) Scoring System Predicts Outcomes of Patients on Active Surveillance.

Wei Shen TanRoberto ContieriNicolò Maria BuffiGiovanni LughezzaniValentina GrajalesMark SolowayPaolo CasaleRodolfo HurleAshish M Kamat
Published in: The Journal of urology (2023)
The IBCG IR-NMIBC scoring system can predict the risk of a subsequent TURBT in patients with LG NMIBC on AS.
Keyphrases
  • muscle invasive bladder cancer
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • type diabetes
  • metabolic syndrome
  • insulin resistance